250 related articles for article (PubMed ID: 10871780)
21. Genetics of multiple sclerosis.
Fukazawa T; Sasaki H; Kikuchi S; Hamada T; Tashiro K
Biomed Pharmacother; 2000 Mar; 54(2):103-6. PubMed ID: 10759295
[TBL] [Abstract][Full Text] [Related]
22. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
23. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
[TBL] [Abstract][Full Text] [Related]
24. On the genetic contribution to selected multifactorial diseases with autoimmune characteristics.
Miterski B; Epplen JT; Gencik M
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):331-41. PubMed ID: 12030439
[TBL] [Abstract][Full Text] [Related]
25. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
26. [Genetic epidemiology of multiple sclerosis].
Uría DF
Rev Neurol; 2002 Nov 16-30; 35(10):979-84. PubMed ID: 12436403
[TBL] [Abstract][Full Text] [Related]
27. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
28. Clinical behavior of multiple sclerosis is modulated by the MHC class I-chain-related gene A.
Fdez-Morera JL; Tunon A; Rodriguez-Rodero S; Rodrigo L; Martinez-Borra J; Gonzalez S; Lopez-Vazquez A; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2006 May; 67(5):409-14. PubMed ID: 16671949
[TBL] [Abstract][Full Text] [Related]
29. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.
Niino M; Fukazawa T; Kikuchi S; Sasaki H
Expert Rev Neurother; 2007 Sep; 7(9):1175-88. PubMed ID: 17868016
[TBL] [Abstract][Full Text] [Related]
31. The genetics of clinical outcome in multiple sclerosis.
Ramagopalan SV; Deluca GC; Degenhardt A; Ebers GC
J Neuroimmunol; 2008 Sep; 201-202():183-99. PubMed ID: 18632165
[TBL] [Abstract][Full Text] [Related]
32. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis genetics: leaving no stone unturned.
Oksenberg JR; Barcellos LF
Genes Immun; 2005 Aug; 6(5):375-87. PubMed ID: 15973459
[TBL] [Abstract][Full Text] [Related]
34. No evidence for association of CTLA-4 gene polymorphisms with the risk of developing multiple sclerosis: a meta-analysis.
Bagos PG; Karnaouri AC; Nikolopoulos GK; Hamodrakas SJ
Mult Scler; 2007 Mar; 13(2):156-68. PubMed ID: 17439880
[TBL] [Abstract][Full Text] [Related]
35. Hormonal factors in susceptibility to multiple sclerosis.
Duquette P; Girard M
Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):195-201. PubMed ID: 8481563
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
[TBL] [Abstract][Full Text] [Related]
37. Exogeneous factors in the aetiology of multiple sclerosis.
Granieri E
J Neurovirol; 2000 May; 6 Suppl 2():S141-6. PubMed ID: 10871802
[TBL] [Abstract][Full Text] [Related]
38. The HLA locus and multiple sclerosis in Sicily.
Brassat D; Salemi G; Barcellos LF; McNeill G; Proia P; Hauser SL; Oksenberg JR; Savettieri G
Neurology; 2005 Jan; 64(2):361-3. PubMed ID: 15668443
[TBL] [Abstract][Full Text] [Related]
39. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
[TBL] [Abstract][Full Text] [Related]
40. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
